Atlas Trials

A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose Symptoms

Clinical trial NCT05264350 · COMPLETED

Trial details

NCT number
NCT05264350
Sponsor
Viiral Nordic AB
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Rhinitis Sicca
Start date
2022-02-03
Primary completion
2022-08-16
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.